Coronavirus: The United States has already set a date for …

The United States plans to launch a coronavirus vaccination program in early December. This was pointed out by the head of the group leading the efforts to deal with the pandemic within the North American government, Moncef Slaoui. “Our plan is to be able to send vaccines to vaccination sites within 24 hours of approval” by the Food and Drug Administration (FDA), the White House adviser said. CNN.

The epidemiologist added: “Hopefully the second day of approval might be December 11 or 12 “.

According to reports FDA advisers to meet December 8-10 to discuss vaccine approval which, according to the laboratories Pfizer and Moderna, have at least one 95 percent effective.

Slaoui also said he hoped that once the mass vaccination campaign started, country could obtain “collective immunity” in May. “Normally, with the level of effectiveness that we have (95%), vaccinating about 70% of the population would give you real herd immunity. It will probably happen in May, or something like that depending on our plans, ”he explained.

“I really hope that the level of negative perception of the vaccine will decrease and that the acceptance by the population will increase. This will be fundamental to help us,” he insisted, alluding to the mistrust of many around the vaccine.

For his part, Anthony Fauci, the foremost American expert in infectious diseases, told the Face the Nation program of CBS That could be 20 million people will be able to be vaccinated from mid to late December“in line with government expectations.

Pfizer and BioNTech have asked the FDA to clear their vaccine

The request which had been awaited for several years was finally sent on Friday, after the publication of the results of the clinical trial carried out since July with 44,000 volunteers in different countries and according to which the vaccine would be 95% effective against Covid-19, no serious side effects.

The U.S. agency announced that a public meeting of its vaccine advisory committee will be held on December 10 to review the request.

The opinion of this committee is advisory. The decision whether or not to authorize the vaccine will depend on scientists at the FDA, and could be taken as early as the first half of December.

The Donald Trump administration plans to vaccinate 20 million people at risk in December, after 25 to 30 million per month.

The United States is one of the countries most affected by the virus: it has recorded 12 million cases and more than 255,000 deaths.